MOTS-c targets mitochondrial function and metabolic efficiency, working through different pathways than AOD-9604
Frequently Asked Questions Common side effects include pain at the injection site, swelling, redness, and mild allergic reactions like itching or rash
Additives : Antioxidants or reducing agents (e.g., DTT) may help, but use cautiously as they can interfere with some assays
It is often sold alongside research peptides because it fits the same metabolic research space, but chemically it is closer to a small-molecule drug than to peptides like BPC-157 or semaglutide
Yes, AOD 9604 is generally well-tolerated by patients with thyroid disorders, perimenopause, or adrenal imbalances
Unit marks are also expressed in mLs and can be interchangeably referenced